openPR Logo
Press release

Explosive Growth in Human Growth Hormone Market Expected by 2019: Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH Human Growth Hormone

07-15-2019 04:54 PM CET | Health & Medicine

Press release from: Worldwide Market Reports

Human Growth Hormone

Human Growth Hormone

Major driver for human growth hormone market is new mergers and acquisitions. For instance, in 2014, Pfizer Inc., a U.S.-based pharmaceutical company, merged with OPKO Health Inc., a U.S.-based company, to develop a long acting growth hormone (hGH-CTP) and to bring innovative treatments for growth hormone deficient patients. hGH-CTP is more convenient, as the patients need to take just one injection in a week rather than daily doses. hGH-CTP has an orphan drug designation in the U.S. and Europe for adults and children with growth hormone deficiency.

Robust pipeline is also expected to support the growth in human growth hormone market size. For instance, Somapacitan sponsored by Novo Nordisk A/S, a Denmark-based company, completed phase 3 clinical trials in 2017. This drug is used for the treatment of growth hormone deficiency in adults. MOD-4023 sponsored by Opko Biologics, an Israel-based company, completed phase 2 clinical trials in 2015. High prevalence of growth hormone deficiency is another factor boosting growth of human growth hormone market. According to a survey conducted by the National Organisation for Rare Diseases (NORA) in 2015, over 10,000 children and 50,000 adults have growth hormone deficiency in the U.S.

However, strict rules and regulations for the use of human growth hormone by athletes and sports professionals is expected to restrain growth of human growth hormone market. The Food and Drug Administration (FDA) and the International Olympic Committee had banned the use of human growth hormone for sports professionals in 2006.

Download the PDF brochure:
www.worldwidemarketreports.com/sample/254191

Human Growth Hormone Market Taxonomy:-

By Application
Growth Hormone Deficiency
Idiopathic short stature
Prader-Willi Syndrome
Turner Syndrome
Others

By Route of Administration
Oral
Intravenous
Subcutaneous
Intramuscular

Europe human growth hormone market is expected to witness significant growth due to mergers and acquisitions. For instance, in 2017, Ferring Pharmaceuticals S.A., a pharmaceutical company, acquired a product i.e. Zoma Jet of Antares Pharma Inc, a pharmaceutical company. Zoma Jet is a needle free auto injectable device. Ferring Pharmaceuticals S.A acquired Zoma Jet in order to increase use of Zomacton (Injectable somatropin hGH). Zoma Jet is used to deliver Zomacton for the treatment of growth hormone deficiency in children and Turner’s syndrome in girls. By acquiring the injectable device Zoma Jet, would eventually lead to increase in use of the drug, Zomacton, which will further encourage Ferring Pharmaceuticals to develop better treatment options for growth hormone deficiency, thereby resulting in growth of the human growth hormone market. Asia Pacific is expected to grow over the forecast period due to robust pipeline. For instance, Cinna Tropin sponsored by Cinnagen, an Iran-based company, completed phase 3 clinical trials in 2017. This drug is used to treat idiopathic short stature in children and adults.

Get HOLISTIC Request Sample Copy Of This Business Report:
www.worldwidemarketreports.com/sample/254191

Table of Contents
Chapter One Human Growth Hormone Industry Overview
Chapter Two Human Growth Hormone Up and Down Stream Industry Analysis
Chapter Three Asia Human Growth Hormone Market Analysis
Chapter Four 2014-2019 Asia Human Growth Hormone Productions Supply Sales Demand Market Status and Forecast
Chapter Five Asia Human Growth Hormone Key Manufacturers Analysis
Chapter Six Asia Human Growth Hormone Industry Development Trend
Chapter Seven North American Human Growth Hormone Market Analysis
Chapter Eight 2014-2019 North American Human Growth Hormone Productions Supply Sales Demand Market Status and Forecast
Chapter Nine North American Human Growth Hormone Key Manufacturers Analysis
Continue . . .

*If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends.

Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Email:sales@worldwidemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Explosive Growth in Human Growth Hormone Market Expected by 2019: Pfizer Inc., Genetech Inc., Merck & Co., Eli Lilly And Company, Novo Nordisk, Sandoz International GmbH Human Growth Hormone here

News-ID: 1804335 • Views:

More Releases from Worldwide Market Reports

Cardiovascular Diseases Stem Cell Therapy Market Expansion Driven by Regenerative Medicine Breakthroughs (2025-2032)
Cardiovascular Diseases Stem Cell Therapy Market Expansion Driven by Regenerativ …
The Cardiovascular Diseases Stem Cell Therapy Market is undergoing significant growth, driven by increasing global prevalence of heart-related disorders, rising demand for regenerative therapies, and expanding advancements in stem cell research. With cardiovascular diseases remaining the leading cause of mortality worldwide, the potential of stem cell-based approaches to repair and regenerate damaged heart tissues is fueling investments, clinical trials, and commercialization efforts. The market is expected to expand substantially during
Cell Gene Therapy Biomanufacturing Market Size, Share, Trends, and Forecast 2025-2032
Cell Gene Therapy Biomanufacturing Market Size, Share, Trends, and Forecast 2025 …
The Cell Gene Therapy Biomanufacturing Market is entering a dynamic growth phase, fueled by rising demand for advanced therapies, expanding clinical pipelines, and the accelerating adoption of personalized medicine. With increasing approvals of cell and gene therapy (CGT) products, growing investments in biopharmaceutical infrastructure, and rapid advancements in bioprocessing technologies, the market is projected to witness substantial expansion between 2025 and 2032. Key Market Drivers Growing Pipeline of Cell & Gene Therapies:
Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size, Share, Trends, and Forecast 2025-2032
Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size, Share, …
The Custom Oligonucleotide Synthesis and Gene Synthesis Service Market is witnessing rapid expansion, driven by growing demand for precision medicine, advancements in synthetic biology, and the increasing use of oligonucleotides in diagnostics, therapeutics, and research applications. With breakthroughs in gene-editing technologies such as CRISPR, rising R&D investments, and the expanding biotechnology and pharmaceutical industry, this market is projected to experience robust growth from 2025 to 2032. FREE SAMPLE DOWNLOAD NOW :
Exclusive Report on High-Throughput Screening Services for Drug Discovery Industry: Market Size will Witness Substantial Growth by 2032|Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.)
Exclusive Report on High-Throughput Screening Services for Drug Discovery Indust …
A new Report by Worldwide Market Reports, titled "High-Throughput Screening Services for Drug Discovery Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032," offers a comprehensive analysis of the industry, which comprises insights on the High-Throughput Screening Services for Drug Discovery market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as

All 5 Releases


More Releases for Hormone

Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market Emer …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Hormone Therapy Market Through 2025? The size of the hormone therapy market has experienced significant growth in the past few years. It is expected to increase from $19.7 billion in 2024 to $21.1 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The growth
Parathyroid Hormone Market Overview: How Parathyroid Hormone Affects Health & Cl …
Parathyroid Hormone Market is predicted to grow at a CAGR 3.4% during the forecast period (2024-2031). Parathyroid Hormone Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so
Estrogen Hormone Replacement: A Vital Segment Driving Growth in the Hormone Repl …
The Hormone Replacement Therapy (HRT) market is experiencing renewed interest, driven by an aging population and a growing understanding of hormonal health. Within this market, the estrogen hormone replacement segment stands out as a high-opportunity area, offering relief from menopausal symptoms and addressing various health concerns. Market Dynamics and Growth Drivers Estrogen HRT plays a crucial role in managing menopausal symptoms, such as hot flashes, night sweats, and vaginal dryness. Beyond symptom
Klinefelter Syndrome Hormone Therapy Market - Balancing Hormones, Unleashing Pot …
Newark, New Castle, USA: The "Klinefelter Syndrome Hormone Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Klinefelter Syndrome Hormone Therapy Market: https://www.growthplusreports.com/report/klinefelter-syndrome-hormone-therapy-market/8775 This latest report researches the
Human Growth Hormone Market - Elevating Lives, Amplifying Growth: Innovations in …
Newark, New Castle, USA - new report, titled Human Growth Hormone Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Growth Hormone market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Human Growth Hormone market. The report offers an overview of
Hormone Replacement Therapy Market Report- Segment by Application Menopause, Hyp …
The Hormone Replacement Therapy Market research report presents an intensive and coordinated exploration of the current circumstance, market key elements, Hormone Replacement Therapy Market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Hormone Replacement Therapy Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans